〒112-0012 東京都文京区大塚5-3-13
一般社団法人 学会支援機構内
お問い合わせ:jsaae@asas-mail.jp

イベントEVENTS


Asian Congress 2016 on Alternatives and Animal Use in the Life Science


Plenary Keynote Lecture
“Phasing Out The Use Of Experimental Animals For Regulatory Risk Assessment Purposes Before 2025”
Herman B.W.M. KOËTER
Chairman of the Alternatives Congress Trust (ACT), Italy


Plenary Lecture 1
“Looking to the Future - WC10: The Three Rs in Action”
Joanne ZURLO
Director of Science Strategy Center for Alternatives to Animal Testing (CAAT),
Johns Hopkins University, USA


Plenary Lecture 2
“BioMed21: Toward a Pathway-Based Paradigm in Health Research”
Troy SEIDLE,et al.
Director of Research & Toxicology Humane Society International, Canada


Session 1 : Asian trends in 3Rs of animal experiments

AS1-1
“The 3R's change after 10 years SNU-IACUC”
Jae-Hak PARK
Laboratory Animal Medicine,College of Veterinary Medicine,Seoul National University, Republic of Korea

AS1-2
“Trends in 3Rs of laboratory animal experiments (Bio-imaging in Singapore)”
Yi Quan Shawn TAY
Comparative Medicine, National University of Singapore (NUS) / Asian Federation of Laboratory Animal Science Associations (AFLAS), Singapore

AS1-3
“Zebrafish, Danio rerio as a replacement alternative”
Mangala GUNATILAKE
Dept of Physiology,Faculty of Medicine, University of Colombo, Sri Lanka

AS1-4
“The Role of an NGO in Implementing Non-Animal Testing and Training Methods in India”
Dipti M. KAPOOR
PETA India, India

AS1-5
“The Study of In Vitro Skin Sensitization Test Based on Integrating 3D Model to h-CLAT”
Shujun CHENG,et al.
Guangdong Inspection and Quarantine Technology Center, China

AS1-6
“Development of reconstructed human epidermal skin equivalent (EPiTRI) and validation of skin irritation test (SIT) protocol by using EPiTRI”
Huey-min LAI,et al.
Center for Drug Development, Industrial Technology Research Institute, Taiwan

AS1-7
“Preparation and characterization of Reconstructed Human Epidermis (RHE)”
Herlina B. SETIJANTI,et al.
Research Center for Drug and Food, National Agency of Drug and Food Control, Indonesia

AS1-8
“Alternative Research (3Rs) in the World, Asia and Japan”
Tsutomu Miki KUROSAWA
Joint Faculty of Veterinary Kagoshima University, Japan


Session 2 : 3Rs in pesticides and chemicals

AS2-1
“Development of 3D reconstructed human cornea-like epithelium, MCTT HCETM from primary limbal cells, and its application for alternative to animal test”
Kyung-Min LIM
College of Pharmacology, Ewha Womans University, Republic of Korea

AS2-2
“Approaches to Reducing Animal Use for Acute Toxicity Testing: Retrospective Analyses of Pesticide Data”
Judy STRICKLAND,et al.
Integrated Laboratory Systems, Inc. / Contractor supporting the NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM), USA

AS2-3
‘3R best practices’ for toxicological evaluation of pesticides ”
Alokparna SENGUPTA
Research & Toxicology Department, Humane Society International, India

AS2-4
“Progress in deleting the 1-year dog study for the safety assessment of pesticides”
Horst SPIELMANN
Inst. For Pharmacy, Faculty for Biology, Chemistry and Pharmacy
Freie Universität Berlin, Germany

AS2-5
“Development of Read-across for Chemical Safety Assessment”
Takashi YAMADA,et al.
Division of Risk Assesment, Biological Safety Research Center, National Institute of Health Sciences, Japan


Session 3 : Cosmetics regulation and alternatives in animal experiments

AS3-1
“Human living skin explant model as an alternative to animal experimentation for evaluation of cosmetic products, raw materials and finished products, activities and tolerance”
Elian LATI,et al.
BIO-EC LABORATORY, France

AS3-2
“Cosmetic regulation and alternatives to animal experiments in Thailand”
Neti WARANUCH,et al.
Cosmetics and Natural products Research Center, Faculty of Pharmaceutical Sciences, Naresuan University / Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences and Center of Excellence for Innovation in Chemistry, Naresuan University, Thailand

AS3-3
“Cosmetic Regulation and Alternatives to Animal Experimentation in India”
Mohammad A. AKBARSHA
Mahatma Gandhi - Doerenkamp Center for Alternatives Bharathidasan University, Tiruchirappalli, India

AS3-4
“Cosmetic regulation and alternative in animal experiments in China”
Rong KUANG
Zhejiang Institute for Food and Drug Control, China

AS3-5
“Face Alternative:Current Status in China”
Lu QIU
Shanghai Entry-Exit Inspection and Quarantine Bureau of China, China

AS3-6
“Development of Alternative Test Methods to Evaluate the Safety of Cosmetics”
Tae Sung KIM,et al.
National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Republic of Korea

AS3-7
“Guidance on use of alternative methods for testing in the safety assessment of cosmetics and quasi-drug”
Hajime KOJIMA,et al.
Division of Risk Assesment, Biological Safety Research Center, National Institute of Health Sciences, Japan


Session 4 : 3Rs in biologicals and others session

AS4-1
“R&D status of alternative test methods for blood products in Korea”
Chiyoung AHN,et al.
Blood Products Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Republic of Korea

AS4-2
“Alternatives and Refinement for Animal Experimentation in Cancer Research”

Arvind INGLE
Scientific Officer ‘G’, Officer-in-Charge, Laboratory Animal Facility, ACTREC, Tata Memorial Centre, Navi Mumbai, India

AS4-3
TOWARDS GLOBAL HARMONIZATION OF 3RS IN BIOLOGICALS – EFFORTS OF THE EPAA BIOLOGICALS TEAM Katrin SCHUTTE,et al.
Katrin SCHUTTE,et al.
Environment European Comission DG Environment, Belgium

AS4-4
3Rs in Quality control of vaccines for human use: opportunities and barriers
Sylvie UHLRICH,et al.
Sanofi Pasteur, France

AS4-5
“Veterinary industry approach to 3Rs in Biologicals”
Takeshi FUJII,et al.
Product Development & Regulatory Affairs, Zoetis Japan, Japan

AS4-6
“VICH(International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Products) and Harmonization of Criteria to Waive TABST(Target Animal Batch Safety Test) for Vaccines for Veterinary Use”
Koji OISHI
National Veterinary Assay Laboratory, JMAFF, Japan


Session 5 : Future approaches to alternatives in 3Rs

AS5-1
“The Use of Adverse Outcome Pathways (AOPs) to Support Chemical Safety Decisions within the Context of Integrated Approaches to Testing and Assessment (IATA)”
Catherine WILLETT
Humane Society of the United States / Humane Society International, USA

AS5-2
“Progress of alternative study in China”
Jufeng WANG
Pharmaron, China

AS5-3
“Mechanism based evaluation system for hepato- and nephrotoxicity or carcinogenicity using omics technology”
Fumiyo SAITO
Chemicals Assessment and Research Center, Chemicals Evaluation and Research Institute, Japan

AS5-4
“Stem cells and alternatives”
Eui-Bae JEUNG
College of Veterinary Medicine, Chungbuk National University, Republic of Korea

AS5-5
“Futuristic approach to alternative model organisms: Hydra stakes its claim”
Mohammad A. AKBARSHA,et al.
Mahatma Gandhi - Doerenkamp Center for Alternatives to Use of Animals in Life Science Education, Bharathidasan University, India



THE LUSH PRIZE Session
(Sponsored by THE LUSH PRIZE)

“In Vitro Testing as a Scientifically Advanced Strategy for Regulatory Safety Compliance and Claim Support in the Global Cosmetics Industry”
Carol TREASURE, et al.
XCellR8 Ltd. UK


Luncheon Seminar 1
(Sponsored by YUTOKU PHARMACEUTICAL IND.Co., LTD.
KANTO CHEMICAL CO., INC.)

“Unique cell culture techniques for in vitro research”
Shigehisa AOKI
Department of Pathology & Microbiology, Saga University Japan

Luncheon Seminar 2
(Sponsored by THE LUSH PRIZE)

“The Lush Prize Young Researcher Asia Award 2016”
Rebecca RAM
Scientific Consultant, Lush Prize, UK


Satellite Session
AOP Training
(Sponsored by Mandom Corporation)

Catherine WILLETT
Humane Society of the United States / Humane Society International, USA

“An Introduction to the AOP Knowledgebase”
Kellie FAY
US Environmental Protection Agency, USA




バナースペース


日本動物実験代替法学会事務局

〒112-0012
東京都文京区大塚5-3-13 
一般社団法人 学会支援機構内

TEL 03-5981-6011
FAX 03-5981-6012
MAIL:jsaae@asas-mail.jp